Patent ID: 7387999
Filing Date: 2008-06-17
Classification: A61K,A61P,C07H

Abstract:
1. A method of inhibiting angiogenesis in humans and animals which comprises administering a therapeutically effective amount of a simmondsin, or esters or salts thereof, to the human or animal in need thereof wherein the simmondsin is selected from the group consisting of 4-desmethylsimmondsin, 5-desmethylsimmondsin, 4,5-didesmethylsimmondsin, 4,5-dimethylsimmondsin, 4-desmethylsimmondsin-2′-ferulate, 5-desmethylsimmondsin-2′-ferulate, 4,5-didesmethylsimmondsin-2′-ferulate, 4,5-dimethylsimmondsin-2′-ferulate, and any mixture thereof.